Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride reduces hirsutism effectively with fewer side effects but is a second-choice treatment due to safety concerns.

Finasteride reduces melanin production, possibly treating hyperpigmentation and melanoma, but needs more safety research.

Estrogen deficiency, like after menopause or certain surgeries, leads to faster skin aging and health issues.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Early hormones shape sex-specific differences in rat glands.

A pregnant woman's skin condition improved after giving birth, possibly due to high estrogen levels during pregnancy.

A mix of Polygonatum sibiricum and Nelumbinis semen may ease menopause symptoms with fewer side effects.

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

Hormonal interactions, especially involving DHT and estrogen, play a key role in BPH development and treatment.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Hair follicles produce and respond to melatonin, affecting hair growth and sensitivity to estrogen.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

After menopause, women lose a lot of skin collagen, but estrogen replacement might improve skin health.

Finasteride reduces hair growth better, but spironolactone has more side effects.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Flutamide reduces hair growth better but has more side effects.

Spironolactone reduces the enzyme activity that converts testosterone to DHT, helping treat excessive hair growth in women.

Finasteride reduces alcohol withdrawal severity in male mice but increases it in female mice.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Estrogen and prolactin may play bigger roles in female hair loss than previously thought.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

Finasteride reduces hair growth in women with hirsutism and works better with electrolysis.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

Finasteride helps reduce heart enlargement in heart failure patients.

Testosterone reduces key molecules needed for early pregnancy in rats.

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.

Testosterone reduces heart damage and inflammation after injury.